Antibacterial Agents TRIZ Cases

Nitrofurfuryl substituted phenyl linked piperidino-oxadiazolone compounds exhibit potent anti-tubercular activity against Mycobacterium tuberculosis strains.

Amphipathic peptoid helices resolve the trade-off between potent antibacterial activity and low mammalian cytotoxicity through asymmetric sequence design.

Short linkers between pyrrolidine rings and guanidine groups boost potency against intracellular pathogens like MRSA.

Targeting purine nucleoside phosphorylase overcomes antibiotic resistance in Helicobacter pylori infections by blocking essential metabolic pathways.

Identifying PGLYRP1 as the TREM-1 ligand enables antibody development for treating chronic inflammatory diseases.

P2X4 receptor agonists stimulate macrophage bactericidal activity to clear infections, addressing antibiotic resistance and immune dysregulation in sepsis.

A chimeric monoclonal antibody targets the RGD sequence in extracellular matrix proteins to inhibit integrin binding.

Smac mimetic compounds displace caspases from XIAP binding sites, restoring apoptotic sensitivity in cancer cells overexpressing IAP proteins.

Peptides targeting the substrate docking site of MAP kinase p38α achieve high potency while reducing off-target toxicity.

Incorporating D-amino acids into polypeptides enables efficient cargo delivery while reducing membrane disruption and cytotoxicity.

Specific IR/DR sequences and FACT complex cofactors increase transposition rates while reducing aberrant single-ended events.

Synthetic agonists and antagonists of the AgrC quorum sensing system control virulence without triggering antibiotic resistance.

Acetone and polyoxyethylene ethers solubilize luliconazole at 5% concentration, preventing crystal deposition at 5°C and stereoisomer formation.

Optimizing the hydrophilic-lipophilic balance of hydrophobic vehicles prevents chlorhexidine degradation while sustaining antimicrobial activity.

Cycloalkyl gallate analogs replace unstable EGCG to maintain neutral pH stability while inducing LL-37 peptides.

DRGN-1 peptide disrupts biofilms and accelerates tissue regeneration to treat multidrug-resistant infections in chronic wounds.

Novel cyclopeptides from Teredinibacter turnerae overcome multidrug resistance in Gram-negative bacteria without mammalian cell toxicity.

Novel antibacterial compound blocks bacterial efflux pumps to sensitize multidrug-resistant bacteria to oxidative stress, restoring antibiotic efficacy.

Block copolymers combine beta-peptide and sugar blocks to target bacteria while maintaining mammalian cell biocompatibility.

Carbapenems acylate L,D-transpeptidases to overcome resistance from altered penicillin binding proteins in tuberculosis.

Fusing lysins with antimicrobial peptides enables artilysins to traverse the outer membrane barrier of Gram-negative bacteria and degrade peptidoglycan.

Extracted PgAMP1 peptide targets Klebsiella and Proteus bacteria, countering synthetic antibiotic resistance.

Deuterium-enriched cyclohexanone compounds extend half-life through kinetic isotope effects.

Fatty acid substitutions on nucleoside scaffolds enhance water solubility and genetic barriers to resistance against multi-drug resistant HIV strains.

Vaccines target resistance proteins to deplete pathogen defenses and reduce infection severity.

Cultivating filamentous Lactobacillus salivarius to bind galectin-9 and permeate M cells.

Coarse non-direct compressible erythritol particles combined with hydroxypropyl cellulose binder form oral delivery tablets.

A 0.2 μm filtrate of spent chemostat media supports growth of previously unculturable human gut anaerobes.

Synthesizing a pyridine-coumarin nicotinonitrile compound via one-pot reaction to exhibit antimicrobial activity.

Propargyl-linked pyrimidine derivatives selectively inhibit pathogenic dihydrofolate reductase while reducing mammalian cell toxicity.

Constrained spirocyclic structures achieve high specificity in CGRP receptor targeting, preventing migraine symptoms through precise molecular recognition.

Truncated antibody Fab fragments enable site-specific effector molecule attachment via exposed C-terminal cysteines.

Nasal microbiome biomarker kits identify high-risk cows to enable targeted antibiotic use, reducing resistance and costs.

A multi-layered epidermal lifting mechanism uses elastic and inelastic sections to secure medical dressings on the body.

Novel thiazolino 2-pyridone compounds bypass antibiotic resistance in Chlamydia trachomatis by inhibiting the hexose-phosphate transporter.

Aza spiro alkane compounds inhibit metalloproteases, preventing excessive tissue degradation in arthritis and cancer.

A four-step chromatography sequence purifies O-EPA bioconjugates for vaccine manufacturing.

Melt-blown saccharide fibers form a nonwoven dressing releasing medicaments directly to wounds, eliminating manual paste preparation.

Engineered hybrid and tandem NMB1870 polypeptides combine sequences from multiple meningococcal families to elicit broad bactericidal antibodies.

A periodontal medicament delivery tray applies specific treatments to distinct oral regions based on identified bacterial communities.

Measuring IL-1α and TNF-α cytokine levels differentiates bacterial infections from non-bacterial causes, reducing antibiotic misuse and resistance.

Selective bicyclic anilide heterocyclic antagonists target CGRP receptors, improving therapeutic efficacy while reducing side effects of existing treatments.

Modified binding interfaces enable variant fold-OB proteins to resist gastric degradation while preserving target affinity.

Combining differential biopanning with next-generation deep sequencing identifies unique antibody clones for low-expressed surface receptors.

Allyl isothiocyanate applied to ungulate hooves prevents and treats hairy wart disease, avoiding antibiotic resistance and milk pollution risks.

Carboxyamidotriazole orotate inhibits endothelial cell proliferation to treat angiogenesis-dependent diseases.

Amino acid substitutions in PIF peptides enhance immune modulation and reduce inflammation for treating neurotrauma.